Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation

Published:2017-12 Issue:12 Volume:23 Page:2070-2078
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Introna Martino,Lussana Federico,Algarotti Alessandra,Gotti Elisa,Valgardsdottir Rut,Micò Caterina,Grassi Anna,Pavoni Chiara,Ferrari Maria Luisa,Delaini Federica,Todisco Elisabetta,Cavattoni Irene,Deola Sara,Biagi Ettore,Balduzzi Adriana,Rovelli Attilio,Parma Matteo,Napolitano Sara,Sgroi Giusy,Marrocco Emanuela,Perseghin Paolo,Belotti Daniela,Cabiati Benedetta,Gaipa Giuseppe,Golay Josée,Biondi Andrea,Rambaldi Alessandro

Funder

Associazione Italiana Ricerca contro il Cancro

Associazione Italiana Lotta alle Leucemie, Linfomi e Mieloma (AIL) sezione Paolo Belli, Bergamo and the Italian Health Ministry

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference42 articles.

1. Haploidentical hematopoietic stem cell transplantation as a platform for post-transplantation cellular therapy;Kongtim;Biol Blood Marrow Transplant,2015

2. Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusions;Nikiforow;Hematol Am Soc Hematol Educ Progr,2014

3. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients;Shulman;Am J Med,1980

4. Relapse after allogeneic hematopoietic cell therapy;van den Brink;Biol Blood Marrow Transplant,2010

5. Donor lymphocyte infusions in AML and MDS: enhancing the graft-versus-leukemia effect;Orti;Exp Hematol,2017

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review;Pathology - Research and Practice;2024-10

2. Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab;Antibodies;2024-08-30

3. Cytokine-induced killer cells: new insights for therapy of hematologic malignancies;Stem Cell Research & Therapy;2024-08-13

4. Cell-Based Treatment in Acute Myeloid Leukemia Relapsed after Allogeneic Stem Cell Transplantation;Biomedicines;2024-08-01

5. Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?;Cells;2024-01-12